Detalles de la búsqueda
1.
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Mol Cancer
; 20(1): 134, 2021 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34654425
Resultados
1 -
1
de 1
1
Próxima >
>>